Latest

Latest FDA News | Page 2

  • Latest FDA news stories and updates. What is happening today? All recent FDA news and developments. Live coverage and timeline of FDA. All you need to know about FDA.
Magic mushroom-infused products appear in Colorado gas stations – what public health officials want consumers to know
BlinkLab Limited (ASX:BB1) Completes Clinical Trial Network for Pivotal FDA Study with Tenth U.S. Site Onboarded
Enhertu granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
Are mental health apps like doctors, yogis, drugs or supplements?
Drug company ads are easy to blame for misleading patients and raising costs, but research shows they do help patients get needed treatment
UNSW Sydney takes lion’s share of cardiovascular research awards
Anthony Rodgers takes out top NSW state award for cardiovascular research award
Menstrual pads and tampons can contain toxic substances – here’s what to know about this emerging health issue
FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
Federal Budget 2026-27: AFSA calls for $5m pilot to validate animal-free methods and improve health research translation
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Should medical marijuana be less stringently regulated? A drug policy expert explains what’s at stake
BlinkLab Receives $822,205 R&D Tax Incentive Refund Relating to Autism Diagnostic Tool Pilot Study and Clinical Research Initiatives
Nexsen advances U.S. market entry with FDA engagement for GBS rapid sensor whilst strengthening leadership team
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
US-approved drug to improve quality of life for people with rare conditionn
Off-label use of COVID-19 vaccines was once discouraged but has become common amid new guidelines
FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs
Brewery waste can be repurposed to make nanoparticles that can fight bacteria
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
16th Annual Meeting of the WHO International Regulatory Cooperation for Herbal Medicines (IRCH)
Digital health is changing – here’s what it means for Australians
Bird Flu Persists In Raw Milk Cheese
Conflict At Counter: When Pharmacists’ And Patients’ Values Collide
Science Costs Money – Research Is Guided By Who Funds It And Why
Deadly Pathogens Found In Commercial Raw Cat Foods
BlinkLab Onboards Vanderbilt Kennedy Center as Seventh U.S. Site for FDA 510(k) Autism Diagnostic Trial
Decades-old drug deployed in fight against mitochondrial diseases
Tackling Ethical Questions About Transcranial Magnetic Stimulation
Avania Strengthens Leadership Team with Appointment of Four New Executives
Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse
FDA approves updated COVID-19 vaccines with new restrictions, potentially limiting access for healthy children
Two years on from Australia’s bold psychedelic experiment, here are our concerns
UWA Steps Up Investment In Cancer Imaging Spinout
How inflammatory bowel disease may accelerate the progression of dementia
The growing fad of ‘microdosing’ mushrooms is leading to an uptick in poison control center calls and emergency room visits
COVID-19 vaccines for kids are mired in uncertainty amid conflicting federal guidance
Vape brands bypass regulations on marketing to young people by using global social media accounts
Longer lashes, lasting damage? What to know about lash serums
WHO recommends injectable lenacapavir for HIV prevention
The AI therapist will see you now: Can chatbots really improve mental health?
Cornell, Wegmans partner to train growers in food safety
‘Gas station heroin’: the drug sold as a dietary supplement that’s linked to overdoses and deaths
RMIT MedTech Invention Goes To Market
BlinkLab (ASX:BB1) Receives U.S. Ethics Approval to Commence Main Phase of FDA 510(k) Diagnostic Trial for Autism
A preservative removed from childhood vaccines 20 years ago is still causing controversy today − a drug safety expert explains

© 2026 - The National Tribune Australia